Skip to content

Matthew R. Moll, MD, MPH

Research Areas: polygenic risk prediction, omics risk prediction, multiple omics, drug repurposing, systems pharmacology, COPD, asthma, pulmonary fibrosis

Matthew Moll is an Instructor in Medicine at the Channing Division of Network Medicine and Associate Physician in the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital (BWH) and Harvard Medical School. He completed his residency in internal medicine at Boston University Medical Center, his fellowship at Brigham and Women’s Hospital, and a Master of Public Health in Quantitative Methods from the T.H. Chan Harvard School of Public Health. He sees patients at BWH and the VA Boston Healthcare System. His research focuses on using genetics and other Omics in early identification and therapeutic intervention for individuals at high risk of chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and related outcomes. Dr. Moll has been at the forefront of using Omics to predict risk of and understand heterogeneity in lung disease. He has demonstrated productivity with over 50 publications which has led to an NIH K award, 8 research awards, and over 20 invited presentations. His research program is oriented toward leveraging Omics data for precision approaches that will alter therapeutic strategies for patients.

remol@channing.harvard.edu

Connect with us.